The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,769.50
Bid: 1,769.00
Ask: 1,769.50
Change: 8.50 (0.48%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,772.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 underperforms global peers on 3i drop, sterling gains

Thu, 14th Nov 2019 09:08

* FTSE 100 down 0.8%, FTSE 250 down 0.3%

* Burberry jumps after Q2 results

* 3i drops after H1 report

* FirstGroup marks worst day in more than a year
(Adds news items, updates to close)

By Shashwat Awasthi and Muvija M

Nov 14 (Reuters) - London's FTSE 100 underperformed its
major global peers on Thursday, suffering its steepest intra-day
drop so far this month as falls in private equity company 3i,
stocks trading ex-dividend and a stronger pound hammered the
exporter-heavy index.

The main index fell 0.8% with 3i Group hitting a
five-month low after striking a cautious tone about new
investment opportunities and as heavyweight components Sainsbury
, Shell and GSK traded without
dividend entitlement.

The mid-cap FTSE 250 was 0.3% lower, with transport
operator FirstGroup dropping nearly 20% on its worst day
since May 2018 after a bigger first-half loss due to a charge
related to its Greyhound bus line business in the U.S..

Dollar earners were among the top drags on the main bourse
as sterling strengthened on hopes that Conservatives will win a
majority in the December election and finally break the deadlock
surrounding Britain's departure from the European Union.

Luxury brand Burberry outperformed the index,
rising 3.4% as the popularity of designer Riccardo Tisci's
collections boosted quarterly sales and offset declines in Hong
Kong where trading was hit by ongoing protests.

A host of trigger points, including weak Chinese factory
output data, anxiety around U.S.-China trade, and political
uncertainty in the U.S. amid an impeachment inquiry into
President Donald Trump also weighed on sentiment globally.

Slowing Chinese factory output growth was another sign of
how Beijing's trade dispute with Washington was weighing on
demand. To that end, China said the countries were holding
in-depth discussions on a "phase one" trade agreement.

"If a deal doesn't go through in the next couple of weeks,
the optimism seen in financial markets will rapidly turn into
pessimism and I wouldn't be surprised to see a 5-10% correction
in equity markets," said Hussein Sayed, Chief Market Strategist
at FXTM.

"At this stage, markets are in a wait-and-see mode until
further developments emerge."

G4S lost 2.4% after Norway's central bank said the
country's wealth fund, the world's largest, can no longer invest
in the security services company because of the risk that it
contributes to, or is responsible for human rights violations.

Airport operator Stobart tumbled 5% on the
small-cap index after suspending its dividend and posting a
bigger first-half loss.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Kirsten
Donovan)

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.